Jethava, Y., Mitchell, A., Zangari, M., Waheed, S., Schinke, C., Thanendrarajan, S., . . . van Rhee, F. (2016). Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma. Blood Cancer J.
Chicago Stili AlıntıJethava, Y., et al. "Dose-dense and Less Dose-intense Total Therapy 5 for Gene Expression Profiling-defined High-risk Multiple Myeloma." Blood Cancer J 2016.
MLA AlıntıJethava, Y., et al. "Dose-dense and Less Dose-intense Total Therapy 5 for Gene Expression Profiling-defined High-risk Multiple Myeloma." Blood Cancer J 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..